Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
about
Targeted therapy for advanced renal cell carcinomaTargeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.Management of locally advanced renal cell carcinoma.New drug therapies for advanced renal cell carcinoma.Novel therapies in genitourinary cancer: an update.Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma.
P2860
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@en
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@nl
type
label
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@en
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@nl
prefLabel
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@en
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@nl
P2093
P356
P1476
Randomized phase II study comp ...... tastatic renal cell carcinoma.
@en
P2093
Barry W Hancock
Chooi P Lee
Debbie A Beirne
Lynda Pyle
Maggie G James
Martin E Gore
Poulam M Patel
Roger A'Hern
Sarah Steeds
P304
P356
10.1200/JCO.2005.03.7309
P407
P50
P577
2006-02-01T00:00:00Z